Bioaffinity Technologies Warrant Stock Number Of Shares Shorted
| BIAFW Stock | USD 0.22 0.08 26.67% |
Fundamental analysis of BioAffinity Technologies allows traders to better anticipate movements in BioAffinity Technologies' stock price by examining its financial health and performance throughout various phases of its business cycle.
BioAffinity | Build AI portfolio with BioAffinity Stock |
bioAffinity Technologies Warrant Company Number Of Shares Shorted Analysis
BioAffinity Technologies' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current BioAffinity Technologies Number Of Shares Shorted | 300 |
Most of BioAffinity Technologies' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, bioAffinity Technologies Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, bioAffinity Technologies Warrant has 300 of outstending shares currently sold short by investors. This is 99.99% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.99% higher than that of the company.
BioAffinity Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioAffinity Technologies' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioAffinity Technologies could also be used in its relative valuation, which is a method of valuing BioAffinity Technologies by comparing valuation metrics of similar companies.BioAffinity Technologies is currently under evaluation in number of shares shorted category among its peers.
BioAffinity Fundamentals
| Return On Equity | -2.45 | ||||
| Return On Asset | -0.72 | ||||
| Profit Margin | (2.17) % | ||||
| Operating Margin | (1.59) % | ||||
| Number Of Shares Shorted | 300 | ||||
| Revenue | 9.36 M | ||||
| Gross Profit | 1.89 M | ||||
| EBITDA | (8.33 M) | ||||
| Net Income | (9.04 M) | ||||
| Cash And Equivalents | 214.4 K | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 1.5 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | 2.57 X | ||||
| Cash Flow From Operations | (7.26 M) | ||||
| Number Of Employees | 57 | ||||
| Beta | 2.42 | ||||
| Total Asset | 6.51 M | ||||
| Retained Earnings | (53.64 M) | ||||
| Working Capital | (409.81 K) | ||||
| Net Asset | 6.51 M |
About BioAffinity Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze bioAffinity Technologies Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioAffinity Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of bioAffinity Technologies Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.